Background: Toxic cardiomyopathies were a potentially fatal adverse effect of anthracycline therapy.
Aim: This study was conducted to demonstrate the pathogenetic, morphologic, and toxicologic effects of doxorubicin on the heart and to investigate how the MAPK /TNF-α pathway can be modulated to improve doxorubicin-Induced cardiac lesions using bone marrow-derived mesenchymal stem cells (BM-MSCs) and olive leaf extract (OLE).
Methods: During the study, 40 adult male rats were used.